ALBEMARLE CORP (ALB) Fundamental Analysis & Valuation

NYSE:ALB • US0126531013

Current stock price

158.22 USD
-5.67 (-3.46%)
At close:
158 USD
-0.22 (-0.14%)
After Hours:

This ALB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALB Profitability Analysis

1.1 Basic Checks

  • ALB had negative earnings in the past year.
  • In the past year ALB had a positive cash flow from operations.
  • In multiple years ALB reported negative net income over the last 5 years.
  • Each year in the past 5 years ALB had a positive operating cash flow.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • ALB's Return On Assets of -4.14% is on the low side compared to the rest of the industry. ALB is outperformed by 68.67% of its industry peers.
  • Looking at the Return On Equity, with a value of -7.11%, ALB is doing worse than 62.65% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 0.37%, ALB is doing worse than 74.70% of the companies in the same industry.
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROIC 0.37%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.34%, ALB is doing worse than 68.67% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALB has declined.
  • ALB has a Gross Margin of 13.00%. This is in the lower half of the industry: ALB underperforms 77.11% of its industry peers.
  • In the last couple of years the Gross Margin of ALB has declined.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 13%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALB is destroying value.
  • The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ALB has more shares outstanding
  • The debt/assets ratio for ALB has been reduced compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.52 indicates that ALB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.52, ALB is doing good in the industry, outperforming 69.88% of the companies in the same industry.
  • ALB has a debt to FCF ratio of 4.61. This is a neutral value as ALB would need 4.61 years to pay back of all of its debts.
  • ALB's Debt to FCF ratio of 4.61 is amongst the best of the industry. ALB outperforms 80.72% of its industry peers.
  • ALB has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • ALB has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ALB outperforms 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Altman-Z 2.52
ROIC/WACC0.03
WACC14.11%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • ALB has a Current Ratio of 2.23. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
  • ALB's Current ratio of 2.23 is fine compared to the rest of the industry. ALB outperforms 61.45% of its industry peers.
  • ALB has a Quick Ratio of 1.57. This is a normal value and indicates that ALB is financially healthy and should not expect problems in meeting its short term obligations.
  • ALB has a better Quick ratio (1.57) than 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.57
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALB Growth Analysis

3.1 Past

  • ALB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.24%, which is quite impressive.
  • ALB shows a decrease in Revenue. In the last year, the revenue decreased by -4.37%.
  • ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.45% yearly.
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 94.11% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.41% on average over the next years. This is quite good.
EPS Next Y1051.57%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue Next Year11.12%
Revenue Next 2Y8.63%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALB Valuation Analysis

4.1 Price/Earnings Ratio

  • ALB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 21.05, which indicates a rather expensive current valuation of ALB.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALB.
  • ALB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE N/A
Fwd PE 21.05
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

  • 79.52% of the companies in the same industry are cheaper than ALB, based on the Enterprise Value to EBITDA ratio.
  • ALB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALB is cheaper than 61.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.93
EV/EBITDA 27.8
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALB's earnings are expected to grow with 149.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y263.09%
EPS Next 3Y149.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ALB Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.99%, ALB is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.09, ALB has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.99, ALB pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

  • On average, the dividend of ALB grows each year by 14.86%, which is quite nice.
  • ALB has paid a dividend for at least 10 years, which is a reliable track record.
  • ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)14.86%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of ALB are negative and hence is the payout ratio. ALB will probably not be able to sustain this dividend level.
  • The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-52.74%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

ALB Fundamentals: All Metrics, Ratios and Statistics

ALBEMARLE CORP

NYSE:ALB (3/13/2026, 8:09:28 PM)

After market: 158 -0.22 (-0.14%)

158.22

-5.67 (-3.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11
Earnings (Next)04-28
Inst Owners94.66%
Inst Owner Change-0.46%
Ins Owners0.32%
Ins Owner Change-4.34%
Market Cap18.65B
Revenue(TTM)5.14B
Net Income(TTM)-677.38M
Analysts76.67
Price Target190.59 (20.46%)
Short Float %7.33%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend3.04
Dividend Growth(5Y)14.86%
DP-52.74%
Div Incr Years30
Div Non Decr Years30
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-28.49%
Max EPS beat(2)75.86%
EPS beat(4)3
Avg EPS beat(4)57.57%
Min EPS beat(4)-28.49%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.89%
EPS beat(12)6
Avg EPS beat(12)-0.71%
EPS beat(16)10
Avg EPS beat(16)3.12%
Revenue beat(2)2
Avg Revenue beat(2)3.19%
Min Revenue beat(2)1.46%
Max Revenue beat(2)4.93%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-7.88%
Max Revenue beat(4)8.39%
Revenue beat(8)5
Avg Revenue beat(8)0.57%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)11.28%
PT rev (3m)74.53%
EPS NQ rev (1m)4731.67%
EPS NQ rev (3m)341.03%
EPS NY rev (1m)173.91%
EPS NY rev (3m)4396.44%
Revenue NQ rev (1m)6.17%
Revenue NQ rev (3m)17.85%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)9.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.05
P/S 3.63
P/FCF 26.93
P/OCF 14.54
P/B 1.96
P/tB 2.38
EV/EBITDA 27.8
EPS(TTM)-0.79
EYN/A
EPS(NY)7.52
Fwd EY4.75%
FCF(TTM)5.88
FCFY3.71%
OCF(TTM)10.88
OCFY6.88%
SpS43.64
BVpS80.89
TBVpS66.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROCE 0.47%
ROIC 0.37%
ROICexc 0.42%
ROICexgc 0.48%
OM 1.34%
PM (TTM) N/A
GM 13%
FCFM 13.46%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-69.86%
ROICexgc growth 5Y-39.71%
ROICexc growth 3Y-69.41%
ROICexc growth 5Y-37.84%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Debt/EBITDA 4.29
Cap/Depr 89.54%
Cap/Sales 11.47%
Interest Coverage 0.38
Cash Conversion 176.29%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.57
Altman-Z 2.52
F-Score5
WACC14.11%
ROIC/WACC0.03
Cap/Depr(3y)292.05%
Cap/Depr(5y)334.21%
Cap/Sales(3y)21.71%
Cap/Sales(5y)22.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
EPS Next Y1051.57%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%
Revenue Next Year11.12%
Revenue Next 2Y8.63%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%
EBIT growth 1Y110.87%
EBIT growth 3Y-67.9%
EBIT growth 5Y-31.38%
EBIT Next Year2213.22%
EBIT Next 3Y201.65%
EBIT Next 5Y117.08%
FCF growth 1Y169.76%
FCF growth 3Y2.33%
FCF growth 5YN/A
OCF growth 1Y86.41%
OCF growth 3Y-12.4%
OCF growth 5Y9.93%

ALBEMARLE CORP / ALB Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALB.


What is the valuation status of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a valuation rating of 4 / 10 to ALBEMARLE CORP (ALB). This can be considered as Fairly Valued.


What is the profitability of ALB stock?

ALBEMARLE CORP (ALB) has a profitability rating of 1 / 10.


What is the financial health of ALBEMARLE CORP (ALB) stock?

The financial health rating of ALBEMARLE CORP (ALB) is 6 / 10.


What is the earnings growth outlook for ALBEMARLE CORP?

The Earnings per Share (EPS) of ALBEMARLE CORP (ALB) is expected to grow by 1051.57% in the next year.